Literature DB >> 23200109

Higher level of faecal SCFA in women correlates with metabolic syndrome risk factors.

Tatiana F S Teixeira1, Łukasz Grześkowiak, Sylvia C C Franceschini, Josefina Bressan, Célia L L F Ferreira, Maria C G Peluzio.   

Abstract

SCFA provide energy to the host and influence lipid and glucose metabolism, suggesting that they may have an impact on the occurrence of metabolic risk factors. The aim of the present study was to determine the concentration of SCFA in faeces of lean and obese individuals and to analyse whether associations between faecal SCFA and metabolic syndrome parameters are present. Lean (n 20) and obese (n 20) women of similar age (28·5 (sd 7·6) v. 30·7 (sd 6·5) years, P= 0·33) participated in the study. Anthropometric measurements, body composition, blood pressure and biochemical parameters were assessed. SCFA were extracted from faeces and quantified by GC. Blood pressure and blood glucose, although within the normal limits, were higher in the obese group compared to lean subjects (P< 0·05). Lower HDL concentration and higher insulin and homeostasis model assessment (HOMA) index were observed in the obese than in the lean group (P< 0·05). The median values of SCFA (% w/w) from the lean and obese groups were butyric (0·021 v. 0·044, P= 0·024), propionic (0·021 v. 0·051, P= 0·007) and acetic (0·03 v. 0·061, P= 0·01). SCFA correlated positively with metabolic syndrome risk factors such as adiposity, waist circumference and HOMA index (P< 0·05), and inversely with HDL (P< 0·05). Our results suggest that the higher faecal concentration of SCFA is associated with metabolic risk factors and thus may influence metabolic homeostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23200109     DOI: 10.1017/S0007114512002723

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  40 in total

Review 1.  Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?

Authors:  Antonio Sircana; Luciana Framarin; Nicola Leone; Mara Berrutti; Francesca Castellino; Renato Parente; Franco De Michieli; Elena Paschetta; Giovanni Musso
Journal:  Curr Diab Rep       Date:  2018-09-13       Impact factor: 4.810

Review 2.  Gut Microbiota: Modulation of Host Physiology in Obesity.

Authors:  Vandana Nehra; Jacob M Allen; Lucy J Mailing; Purna C Kashyap; Jeffrey A Woods
Journal:  Physiology (Bethesda)       Date:  2016-09

3.  Antioxidant Drug Tempol Promotes Functional Metabolic Changes in the Gut Microbiota.

Authors:  Jingwei Cai; Limin Zhang; Richard A Jones; Jared B Correll; Emmanuel Hatzakis; Philip B Smith; Frank J Gonzalez; Andrew D Patterson
Journal:  J Proteome Res       Date:  2016-01-12       Impact factor: 4.466

4.  Brief overview of dietary intake, some types of gut microbiota, metabolic markers and research opportunities in sample of Egyptian women.

Authors:  Nayera E Hassan; Salwa M El Shebini; Sahar A El-Masry; Nihad H Ahmed; Ayat N Kamal; Ahmed S Ismail; Khadija M Alian; Mohammed I Mostafa; Mohamed Selim; Mahmoud A S Afify
Journal:  Sci Rep       Date:  2022-10-14       Impact factor: 4.996

5.  Consumption of a Bifidobacterium bifidum Strain for 4 Weeks Modulates Dominant Intestinal Bacterial Taxa and Fecal Butyrate in Healthy Adults.

Authors:  Giorgio Gargari; Valentina Taverniti; Silvia Balzaretti; Chiara Ferrario; Claudio Gardana; Paolo Simonetti; Simone Guglielmetti
Journal:  Appl Environ Microbiol       Date:  2016-09-16       Impact factor: 4.792

6.  Microbiota-Dependent Hepatic Lipogenesis Mediated by Stearoyl CoA Desaturase 1 (SCD1) Promotes Metabolic Syndrome in TLR5-Deficient Mice.

Authors:  Vishal Singh; Benoit Chassaing; Limin Zhang; Beng San Yeoh; Xia Xiao; Manish Kumar; Mark T Baker; Jingwei Cai; Rachel Walker; Kamil Borkowski; Kevin J Harvatine; Nagendra Singh; Gregory C Shearer; James M Ntambi; Bina Joe; Andrew D Patterson; Andrew T Gewirtz; Matam Vijay-Kumar
Journal:  Cell Metab       Date:  2015-10-29       Impact factor: 27.287

Review 7.  Gut microbiome as a novel cardiovascular therapeutic target.

Authors:  Vishal Singh; Beng San Yeoh; Matam Vijay-Kumar
Journal:  Curr Opin Pharmacol       Date:  2016-01-30       Impact factor: 5.547

Review 8.  Gut microbial metabolites in obesity, NAFLD and T2DM.

Authors:  Emanuel E Canfora; Ruth C R Meex; Koen Venema; Ellen E Blaak
Journal:  Nat Rev Endocrinol       Date:  2019-05       Impact factor: 43.330

9.  Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease.

Authors:  Monika Rau; Ateequr Rehman; Marcus Dittrich; Albert K Groen; Heike M Hermanns; Florian Seyfried; Niklas Beyersdorf; Thomas Dandekar; Philip Rosenstiel; Andreas Geier
Journal:  United European Gastroenterol J       Date:  2018-09-30       Impact factor: 4.623

Review 10.  Gut microbiota in obesity.

Authors:  Bing-Nan Liu; Xiao-Tong Liu; Zi-Han Liang; Ji-Hui Wang
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.